These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 6395991)

  • 21. Xylitol as osmotic agent in CAPD: an alternative to glucose for uremic diabetic patients?
    Bazzato G; Coli U; Landini S; Fracasso A; Morachiello P; Righetto F; Scanferla F; Onesti G
    Trans Am Soc Artif Intern Organs; 1982; 28():280-6. PubMed ID: 6761936
    [No Abstract]   [Full Text] [Related]  

  • 22. Diabetes, intraperitoneal insulin, and CAPD.
    Cohen IM; Lee S
    Clin Exp Dial Apheresis; 1981; 5(3):269-75. PubMed ID: 7037250
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Plasma biochemistries in CAPD patients from overnight-dwell dialysate.
    Spencer PC; Forbes SM; Farrell PC
    Trans Am Soc Artif Intern Organs; 1984; 30():241-3. PubMed ID: 6533892
    [No Abstract]   [Full Text] [Related]  

  • 24. Continuous ambulatory peritoneal dialysis (CAPD).
    Mulgaonkar S; Lyman N; Viscuso R; Jacobs MG
    J Med Soc N J; 1983 Jun; 80(6):427-30. PubMed ID: 6577192
    [No Abstract]   [Full Text] [Related]  

  • 25. Carbohydrate and lipid metabolism during continuous ambulatory peritoneal dialysis (CAPD): the effect of a single dialysis cycle.
    Heaton A; Johnston DG; Burrin JM; Orskov H; Ward MK; Alberti KG; Kerr DN
    Clin Sci (Lond); 1983 Nov; 65(5):539-45. PubMed ID: 6352157
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Demographic factors associated with dialysis technique failures among patients undergoing continuous ambulatory peritoneal dialysis.
    Rubin J; Kirchner K; Ray R; Bower JD
    Arch Intern Med; 1985 Jun; 145(6):1041-4. PubMed ID: 4004428
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Efficacy of the administration of intraperitoneal insulin in diabetic patients undergoing continuous ambulatory peritoneal dialysis].
    Coronel Díaz F; Naranjo Gómez P; Serrano Heranz R; Cruceyra Ventín A; Prats Sánchez D
    Med Clin (Barc); 1984 May; 82(20):881-4. PubMed ID: 6379332
    [No Abstract]   [Full Text] [Related]  

  • 28. Marked variation in peritoneal insulin absorption in peritoneal dialysis.
    Fine A; Parry D; Ariano R; Dent W
    Perit Dial Int; 2000; 20(6):652-5. PubMed ID: 11216554
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Intermittent peritoneal dialysis and continuous ambulatory peritoneal dialysis].
    Rev Infirm; 1985 Jan; 35(1):49-60. PubMed ID: 3845636
    [No Abstract]   [Full Text] [Related]  

  • 30. The nutritional/metabolic and hormonal effects of 8 weeks of continuous ambulatory peritoneal dialysis with a 1% amino acid solution.
    Arfeen S; Goodship TH; Kirkwood A; Ward MK
    Clin Nephrol; 1990 Apr; 33(4):192-99. PubMed ID: 2190721
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Experimental study of chronic ambulatory peritoneal dialysis. I. Inhibition of protein and amino acid losses by single amino acids.
    Wells IC; Durr MP; Grabner BJ; Holladay FP; Campbell AS; Zielinski CM; Hammeke MD; Egan JD
    Clin Physiol Biochem; 1985; 3(1):8-15. PubMed ID: 3995871
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Continuous ambulatory peritoneal dialysis, CAPD. 18-month experience with a new form of treatment of chronic renal failure].
    Ekelund B; Jørgensen JI
    Ugeskr Laeger; 1982 Sep; 144(38):2776-9. PubMed ID: 7157503
    [No Abstract]   [Full Text] [Related]  

  • 33. Icodextrin - still a cause for concern with blood glucose monitoring in continuous ambulatory peritoneal dialysis patients with diabetes.
    Slim S; Griffiths MJ; Gama R
    Ann Clin Biochem; 2007 Mar; 44(Pt 2):196-7. PubMed ID: 17362588
    [No Abstract]   [Full Text] [Related]  

  • 34. Automated and continuous ambulatory peritoneal dialysis have similar outcomes.
    Badve SV; Hawley CM; McDonald SP; Mudge DW; Rosman JB; Brown FG; Johnson DW
    Kidney Int; 2008 Feb; 73(4):480-8. PubMed ID: 18046315
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Continuous ambulatory peritoneal dialysis in the treatment of end-stage diabetic nephropathy.
    Grefberg N; Danielson BG; Nilsson P
    Acta Med Scand; 1984; 215(5):427-34. PubMed ID: 6377827
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Continuous ambulatory peritoneal dialysis: 3 years' experience].
    Ryckelynck JP; Peny J; Landru I; Batho JM; Beuve-Mery P
    LARC Med; 1982 Oct; 2(9):732, 735-9. PubMed ID: 6819418
    [No Abstract]   [Full Text] [Related]  

  • 37. Continuous ambulatory peritoneal dialysis.
    Ainge RM
    Nurs Times; 1981 Sep 16-22; 77(38):1036-8. PubMed ID: 6912514
    [No Abstract]   [Full Text] [Related]  

  • 38. Effect of peritonitis on insulin and glucose absorption during peritoneal dialysis in diabetic rats.
    Mactier RA; Moore H; Khanna R; Shah J
    Nephron; 1990; 54(3):240-4. PubMed ID: 2179758
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Continuous ambulatory peritoneal dialysis. Old wine in a new container].
    Enger E
    Tidsskr Nor Laegeforen; 1982 Nov; 102(32):1680-1. PubMed ID: 7167936
    [No Abstract]   [Full Text] [Related]  

  • 40. Is continuous ambulatory peritoneal dialysis the best dialysis choice for insulin dependent diabetics?
    Rottembourg J; de Groc F; Poignet JL; Legrain M
    Proc Eur Dial Transplant Assoc; 1983; 19():215-20. PubMed ID: 6348737
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.